当前位置: X-MOL 学术Eur. J. Clin. Investig. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)
European Journal of Clinical Investigation ( IF 5.5 ) Pub Date : 2021-08-19 , DOI: 10.1111/eci.13582
Ibrahim El-Battrawy 1 , Ivan J Nuñez-Gil 2 , Mohammad Abumayyaleh 1 , Vicente Estrada 2 , Víctor Manuel Becerra-Muñoz 3 , Aitor Uribarri 4 , Inmaculada Fernández-Rozas 5 , Gisela Feltes 6 , Ramón Arroyo-Espliguero 7 , Daniela Trabattoni 8 , Javier López-País 9 , Martino Pepe 10 , Rodolfo Romero 11 , Alex F Castro-Mejía 12 , Enrico Cerrato 13 , Thamar Capel Astrua 14 , Fabrizio D'Ascenzo 15 , Oscar Fabregat-Andres 16 , Jaime Signes-Costa 17 , Francisco Marín 18 , Danilo Buonsenso 19 , Alfredo Bardají 20 , María Jesús Tellez 2 , Antonio Fernández-Ortiz 2 , Carlos Macaya 2 , Ibrahim Akin 1
Affiliation  

A systematic analysis of concomitant arterial hypertension in COVID-19 patients and the impact of angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) have not been studied in a large multicentre cohort yet. We conducted a subanalysis from the international HOPE Registry (https://hopeprojectmd.com, NCT04334291) comparing COVID-19 in presence and absence of arterial hypertension.

中文翻译:

COVID-19 和动脉高血压的影响——国际 HOPE COVID-19 登记处的分析(意大利-西班牙-德国)

尚未在大型多中心队列中对 COVID-19 患者合并的动脉高血压以及血管紧张素转换酶抑制剂 (ACEI) 或血管紧张素受体阻滞剂 (ARB) 的影响进行系统分析。我们从国际 HOPE 登记处 (https://hopeprojectmd.com, NCT04334291) 进行了一项子分析,比较了 COVID-19 在存在和不存在动脉高血压的情况下。
更新日期:2021-10-17
down
wechat
bug